Lead
On February 13, 2025, the United States and India announced a framework for an Interim Agreement to guide reciprocal trade measures and deepen cooperation as negotiations continue toward a full Bilateral Trade Agreement (BTA). The framework, issued by both governments, outlines tariff changes, commitments on non-tariff barriers, and provisions to strengthen supply-chain and economic-security alignment. It aims to expand market access for U.S. industrial and agricultural exports while applying a reciprocal tariff regime to a range of Indian-origin goods. Both sides describe the framework as a milestone intended to accelerate final BTA talks and enlarge two-way commerce over the coming years.
Key Takeaways
- India has agreed to eliminate or reduce tariffs on all U.S. industrial goods and a broad set of U.S. food and agricultural products, including dried distillers’ grains (DDGs), red sorghum for animal feed, tree nuts, fresh and processed fruit, soybean oil, wine and spirits.
- The U.S. will apply an 18% reciprocal tariff under Executive Order 14257 (April 2, 2025) on certain originating Indian goods such as textiles, leather, footwear, plastics, organic chemicals, home décor and selected machinery.
- Subject to completing the Interim Agreement, the United States will remove its reciprocal tariff on additional Indian goods listed in the Potential Tariff Adjustments Annex to Executive Order 14346 (September 5, 2025), including generic pharmaceuticals, gems and diamonds, and aircraft parts.
- The U.S. will lift tariffs on certain Indian aircraft and parts imposed under Proclamations 9704/9705 (March 8, 2018) and 10962 (July 30, 2025); India will receive a preferential tariff-rate quota for some automotive parts tied to Proclamation 9888 (May 17, 2019).
- Both countries commit to rules of origin that ensure benefits mainly accrue to U.S. and Indian firms and to address non-tariff barriers in sectors such as medical devices, ICT goods, and food and agriculture.
- India intends to purchase $500 billion of U.S. products over the next five years, including energy, aircraft and parts, precious metals, technology products and coking coal.
- The framework pledges cooperation on economic-security alignment: expanding technology trade (notably GPUs and data-center goods), investment-review coordination, export controls and measures to counter non-market third-party policies.
Background
The bilateral BTA negotiations were launched on February 13, 2025, by President Donald J. Trump and Prime Minister Narendra Modi to create a comprehensive trade and investment accord. Negotiations followed years of intermittent trade talks, growing economic ties, and mutual interest in deepening strategic economic cooperation amid shifting global supply chains. Both countries have used tariffs and trade remedies in recent years to address perceived imbalances and national-security concerns, resulting in proclamations and executive orders that factor into the present framework.
India and the United States have complementary trade profiles: the U.S. exports high-value industrial, agricultural and technology goods, while India exports textiles, pharmaceuticals, and increasingly sophisticated information-technology and services. Political and commercial stakeholders on both sides have pushed for outcomes that protect sensitive domestic sectors while unlocking new opportunities for exporters. The Interim Agreement framework is designed to balance these competing pressures and provide a predictable path to broader BTA commitments.
Main Event
The framework sets concrete tariff and market-access steps. India will remove or cut tariffs on a wide set of U.S. industrial and agricultural products, explicitly naming items such as DDGs, red sorghum, tree nuts, fresh and processed fruit, soybean oil, wine and spirits among the covered agricultural goods. Those reductions are intended to expand U.S. exporters’ access to India’s market.
On the U.S. side, officials will apply an 18% reciprocal tariff under EO 14257 to specified Indian-origin goods including textiles and apparel, leather and footwear, plastics and rubber, organic chemicals, home décor, artisanal products and certain machinery. The framework conditions the removal of that reciprocal tariff on concluding the Interim Agreement and on items listed for potential adjustment under EO 14346—examples cited include generic pharmaceuticals, gems and diamonds, and aircraft parts.
The agreement also addresses tariffs imposed for national-security reasons. The United States will remove some tariffs on Indian aircraft and parts tied to earlier 2018 and 2025 proclamations, while India will receive a preferential tariff-rate quota for certain automotive parts covered by Proclamation 9888. The framework further links specific outcomes to the ongoing U.S. Section 232 investigation into pharmaceuticals and pharmaceutical ingredients.
Beyond tariffs, the two governments committed to tackle long-standing non-tariff barriers: India will address restrictions affecting U.S. medical devices, ease restrictive import licensing for ICT goods, and within six months of the agreement’s entry into force will decide whether U.S.-developed or international standards and testing requirements can be used for certain U.S. exports. Both sides agreed to discuss standards and conformity-assessment procedures to simplify compliance.
Analysis & Implications
Economically, tariff reductions by India on U.S. industrial and agricultural goods could lift U.S. export volumes in sectors that have faced market access constraints, particularly agriculture and high-value manufactured goods. The reciprocal 18% U.S. tariff on targeted Indian goods is likely to shield some U.S. domestic industries while creating leverage to negotiate phased tariff removals tied to concrete market-access gains.
For India, negotiated access and a $500 billion purchase intent signal a major commercial opportunity to secure inputs—energy, technology and capital goods—needed for rapid industrial growth. Expanded access to GPUs and data-center equipment could accelerate India’s digital infrastructure build-out, while purchases of aircraft and parts support aviation sector expansion. The scale and composition of the $500 billion figure will drive which sectors see the largest near-term gains.
Strategically, the framework strengthens U.S.-India economic alignment amid broader geopolitical competition. Cooperation on investment screening, export controls and countering non-market third-party policies points to a deeper economic-security partnership that could influence regional supply chains and third-country trade relations, particularly with major trading partners that follow different industrial policies.
Implementation risks remain: domestic political opposition in both capitals, the outcomes of the U.S. Section 232 pharmaceutical probe, and detailed rule-setting (rules of origin, standards, quotas) could slow or narrow expected benefits. The framework creates a roadmap but leaves significant technical and legal work for negotiators to convert the framework into enforceable commitments.
Comparison & Data
| Commitment | Illustrative Items | Timing/Condition |
|---|---|---|
| India tariff cuts | Industrial goods; DDGs; red sorghum; tree nuts; fruit; soybean oil; wine | Immediate in framework; implementation schedule to be negotiated |
| U.S. reciprocal tariff | Textiles, leather, plastics, organic chemicals, machinery | 18% under EO 14257; contingent removals tied to EO 14346 annex |
| Purchases | Energy, aircraft & parts, precious metals, tech products, coking coal | India intends $500 billion over 5 years |
The table summarizes headline commitments. It does not capture detailed product-by-product phase-ins, safeguard clauses, quota formulas or rules-of-origin thresholds that negotiators must define. Those implementation details will determine the practical scale of market access and who benefits within each economy.
Reactions & Quotes
Officials framed the framework as a pragmatic step to lock in near-term trade concessions while preserving momentum toward a full BTA. Business groups in affected sectors signaled cautious optimism, and some domestic stakeholders indicated they will scrutinize implementation details.
“This framework represents a historic milestone in the U.S.-India economic partnership aimed at reciprocal, balanced trade.”
Joint U.S.-India Statement (Official)
The joint statement language emphasizes reciprocity and balance as guiding principles, intended to reassure constituencies in both countries that concessions are mutual and conditional on durable outcomes.
“The agreement opens notable market access for exporters while tying tariff relief to concrete, verifiable outcomes through negotiating texts and annexes.”
U.S. Government summary (Official)
Unconfirmed
- The exact implementation schedule for India’s tariff eliminations and any product-specific phase-ins have not been published in detail and remain to be negotiated.
- The final scope and timing of the United States’ removal of reciprocal tariffs for products listed under EO 14346 are contingent on the completed Interim Agreement and have not been confirmed.
- The outcomes tied to the U.S. Section 232 investigation of pharmaceuticals and ingredients are unresolved and could materially affect concessions on generic drugs.
Bottom Line
The Interim Agreement framework is a substantive, negotiated roadmap that locks in reciprocal commitments across tariffs, market access and regulatory cooperation, while preserving the partnership’s momentum toward a comprehensive BTA. If implemented fully, the framework can significantly increase bilateral trade and deepen economic-security cooperation, particularly in technology and energy sectors.
However, the framework leaves detailed legal and technical work to negotiators—rules of origin, quotas, timelines and the Section 232 pharmaceutical findings are key unknowns that will determine winners and losers within each economy. Stakeholders should watch implementation schedules and the forthcoming negotiating texts for precise obligations and enforcement mechanisms.